thiazole-pleuromutilin

Xian-Long Qi1, He-Chao Zhang1, Xiao Xu1

  • 1Key Lab of New Animal Drug of Gansu Province, Key Lab of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou, 730050, PR China.

概括

一种新型的 thiazole-pleuromutilin衍生物,h19,显示出强大的抗菌活性对抗抗甲素耐药黄金葡萄球菌 (MRSA). 它在临床前模型中显示出有希望的疗效,低毒性和改善的生存率,表现优于 tiamulin.